Datar Cancer Genetics


'Game Changer' Blood Test Detects Breast Cancer

Date – July 24, 2022

‘Game-changer’ blood test detects breast cancer earlier than X-rays, study shows.

Read More

Landmark Liquid Biopsy Study

Date – July 13, 2022

Landmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer.

Read More

The London Clinic

Date – April 11, 2022

Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services

Read More

FDA - Prostate Cancer

Date – February 14, 2022

Datar’s TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.

Read More

South Africa

Date – February 2, 2022

Groundbreaking high-sensitivity cancer screening test arriving in SA ahead of World Cancer Day.

Read More


Date – December 7, 2021

Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait.

Read More

FDA - Breast Cancer

Date – November 19, 2021

US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics.

Read More

The Healthcare Technology Report

Date – October 19, 2021

The Top 25 Women Leaders in Biotechnology of 2021 (Swati Deshpande – Datar Cancer Genetics)

Read More


Date – July 13, 2021

UK – National Institute for Health and Care Excellence (NICE) issues MedTech Innovation Briefing on ‘Trublood-Prostate’ for Precision Non-Invasive Prostate Cancer Diagnosis Described by Experts as a ‘Game Changer’.

Read More